DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Germany
  • /
  • Healthcare
Author Program NEWCreate Narrative
PHH2 logo

Paul Hartmann AG Stock Price

DB:PHH2 Community·€706.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

PHH2 Share Price Performance

€201.00
-20.00 (-9.05%)
​
€201.00
-20.00 (-9.05%)
​
Price €201.00
Fri, 11 Sep 26
Share Pricen/a

PHH2 Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Solid track record with excellent balance sheet and pays a dividend.

0 Risks
3 Rewards
View Full Analysis

Paul Hartmann AG Key Details

€2.5b

Revenue

€1.0b

Cost of Revenue

€1.5b

Gross Profit

€1.4b

Other Expenses

€99.9m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
28.13
59.05%
4.02%
25.8%
View Full Analysis

About PHH2

Founded
1818
Employees
9881
CEO
Britta Fuenfstueck
WebsiteView website
hartmann.info

Paul Hartmann AG manufactures and sells medical and care products in Germany, the rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Wound Care, Incontinence Management, and Infection Management. It offers absorbent underwear, incontinence pads and pants, and fixation pants; medical skincare products; wound management products, such as hydro active wound and silicone SAP dressings, post-op dressings, nature care, adhesive fixation, non-adhesive fixation, gauze, sponges/tamponades, contact layers, absorption pads, cotton, and negative pressure wound therapy; compression, universal, zinc paste, and padding bandages; and hands, skin, surface, instruments, and equipment disinfection and hygiene products. In addition, the company sells operating theater products, including surgical drapes, operating theater clothing, surgical gloves, surgical absorbents and instruments; various Mediset products; patient care products, such as hygiene and maternity products, examination gloves, and nursing care products; diagnostics, such as blood pressure monitors, scale, and thermometers; first aid products; and cotton wool and cosmetic products. It sells its products under the CombiSet, DermaPlast, MoliCare, Sterillium, Veroval, and Zetuvit brands. Paul Hartmann AG was founded in 1818 and is headquartered in Heidenheim, Germany.

Recent PHH2 News & Updates

Analysis Article • Mar 27

There May Be Reason For Hope In Paul Hartmann's (FRA:PHH2) Disappointing Earnings

The market for Paul Hartmann AG's ( FRA:PHH2 ) shares didn't move much after it posted weak earnings recently. We did...

Recent updates

No updates

Paul Hartmann AG Competitors

COP logo

CompuGroup Medical SE KGaA

Symbol: HMSE:COP
Market cap: €1.4b
RHK logo

RHÖN-KLINIKUM

Symbol: XTRA:RHK
Market cap: €977.3m
EUZ logo

Eckert & Ziegler

Symbol: XTRA:EUZ
Market cap: €769.1m
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide